Total Clarity Wealth Management’s Nephros NEPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,657
Closed -$3K 710
2022
Q2
$3K Buy
+1,657
New +$4.47K ﹤0.01% 890
2022
Q1
Sell
-715
Closed -$4K 656
2021
Q4
$4K Buy
715
+62
+9% +$453 ﹤0.01% 843
2021
Q3
$6K Buy
+653
New +$5.66K ﹤0.01% 787
2021
Q2
Sell
-653
Closed -$4K 544
2021
Q1
$4K Buy
+653
New +$5.15K ﹤0.01% 727

Other funds holding NEPH

Total Clarity Wealth Management's NEPH Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Nephros (NEPH) in Q3 2022, closing a stake of 1,657 shares — an estimated $3K sold.

Total Clarity Wealth Management first reported a position in NEPH in Q1 2021 and held it in 4 quarters. The position peaked at $6K in Q3 2021. 18 funds tracked by Wall St. Rank hold NEPH as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Nephros position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 1,657 Nephros shares in Q3 2022, an estimated $3K.
  • Total Clarity Wealth Management first reported a position in Nephros in Q1 2021 and held it in 4 quarters.
  • Total Clarity Wealth Management's Nephros position peaked at $6K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Nephros as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.